Bayesian Statistics, Miscellaneous Statistics

He’s skeptical about Neuroskeptic’s skepticism

FavoriteLoadingAdd to favorites

Jim Delaney writes: Through a link in the weekend reads on Retraction Watch, I read Neuroskeptic’s post-publication peer review of a study on an antidepressant application of the drug armodafinil. Neuroskeptic’s main criticism is that he/she feels that a “conclusion” in the abstract is misleading, “… Adjunctive armodafinil 150 mg/day reduced depressive symptoms associated with bipolar disorder to a greater…
Original post: He’s skeptical about Neuroskeptic’s skepticism
Source: Andrew Gelman